DK0741788T3 - Induktion af tolerans med tolerogene fusionsproteiner - Google Patents

Induktion af tolerans med tolerogene fusionsproteiner

Info

Publication number
DK0741788T3
DK0741788T3 DK95910220T DK95910220T DK0741788T3 DK 0741788 T3 DK0741788 T3 DK 0741788T3 DK 95910220 T DK95910220 T DK 95910220T DK 95910220 T DK95910220 T DK 95910220T DK 0741788 T3 DK0741788 T3 DK 0741788T3
Authority
DK
Denmark
Prior art keywords
epitopes
immunoglobulin
tolerogenic
tolerance
inducing
Prior art date
Application number
DK95910220T
Other languages
Danish (da)
English (en)
Inventor
David W Scott
Elias T Zambidis
Original Assignee
American Nat Red Cross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Nat Red Cross filed Critical American Nat Red Cross
Application granted granted Critical
Publication of DK0741788T3 publication Critical patent/DK0741788T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Burglar Alarm Systems (AREA)
  • Control Of High-Frequency Heating Circuits (AREA)
  • Fuses (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
DK95910220T 1994-02-14 1995-02-10 Induktion af tolerans med tolerogene fusionsproteiner DK0741788T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/195,874 US5817308A (en) 1994-02-14 1994-02-14 Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance
PCT/US1995/001671 WO1995021926A1 (en) 1994-02-14 1995-02-10 Inducing tolerance with tolerogenic fusion proteins

Publications (1)

Publication Number Publication Date
DK0741788T3 true DK0741788T3 (da) 2005-05-30

Family

ID=22723177

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95910220T DK0741788T3 (da) 1994-02-14 1995-02-10 Induktion af tolerans med tolerogene fusionsproteiner

Country Status (10)

Country Link
US (2) US5817308A (de)
EP (1) EP0741788B1 (de)
JP (2) JPH09509316A (de)
AT (1) ATE288494T1 (de)
CA (1) CA2182977A1 (de)
DE (1) DE69533979T8 (de)
DK (1) DK0741788T3 (de)
ES (1) ES2233940T3 (de)
PT (1) PT741788E (de)
WO (1) WO1995021926A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817308A (en) * 1994-02-14 1998-10-06 University Of Rochester Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance
US6485726B1 (en) * 1995-01-17 2002-11-26 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
US5843462A (en) * 1995-11-30 1998-12-01 Regents Of The University Of Minnesota Diphtheria toxin epitopes
CA2315537A1 (en) 1997-12-16 1999-06-24 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
JP3471006B2 (ja) * 1998-05-20 2003-11-25 中外製薬株式会社 新規な遺伝子クローニング方法
US6884785B2 (en) * 1999-06-17 2005-04-26 The Scripps Research Institute Compositions and methods for the treatment or prevention of autoimmune diabetes
AU2001262216A1 (en) * 2000-04-22 2001-11-07 Stefan Barth Apoptotic agents
BR0114105A (pt) 2000-09-25 2003-07-29 Nestle Sa Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas
WO2002085933A1 (en) 2001-04-20 2002-10-31 The Institute For Systems Biology Toll-like receptor 5 ligands and methods of use
US8703146B2 (en) * 2001-04-20 2014-04-22 Institute For Systems Biology Toll-like receptor 5 ligands and methods of use
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US20120148585A1 (en) * 2001-05-01 2012-06-14 Andrew Saxon Fusion molecules and methods for treatment of immune diseases
US8609091B2 (en) 2002-04-09 2013-12-17 The Curators Of The University Of Missouri Method for endocytic presentation of an immunosuppressive for the treatment of type 1 diabetes
US8603472B2 (en) * 2002-04-09 2013-12-10 The Curators Of The University Of Missouri Methods and compositions reversing pre-diabetes using fusion proteins comprising a GAD peptide
US8603471B2 (en) * 2002-04-09 2013-12-10 The Curators Of The University Of Missouri Methods and compositions for preventing the onset of type 1 diabetes
US7744876B2 (en) 2002-04-09 2010-06-29 The Curators Of The University Of Missouri Methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes
US8025873B2 (en) 2002-06-20 2011-09-27 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8029803B2 (en) 2002-06-20 2011-10-04 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8007805B2 (en) * 2003-08-08 2011-08-30 Paladin Labs, Inc. Chimeric antigens for breaking host tolerance to foreign antigens
TW200732346A (en) * 2005-10-13 2007-09-01 Virexx Medical Corp Chimeric hepatitis C virus antigens for eliciting an immune response
KR20170037677A (ko) 2007-01-30 2017-04-04 에피백스, 인크. 조절 ｔ 세포 에피토프, 그의 조성물 및 용도
ES2432863T3 (es) 2009-03-23 2013-12-05 Pin Pharma, Inc. Tratamiento del cáncer con polipéptidos inmunoestimuladores derivados de Tat del VIH
EP2827890B1 (de) 2012-03-23 2019-08-28 The University Of Queensland Immunomodulatorischer wirkstoff und verwendungen dafür
JP2016533352A (ja) 2013-10-04 2016-10-27 ピーアイエヌ ファーマ インコーポレイテッド 免疫刺激性ＨＩＶ Ｔａｔ誘導体ポリペプチドによる癌の治療

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0460076B1 (de) * 1989-02-24 1995-11-29 The Regents Of The University Of California Gentechnologisch veränderte immunglobuline
US6248332B1 (en) * 1990-10-05 2001-06-19 Medarex, Inc. Targeted immunostimulation with bispecific reagents
GB9021679D0 (en) * 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
US5167956A (en) * 1991-02-11 1992-12-01 The United States Of America As Represented By The Department Of Health And Human Services Immunotoxin with in-vivo t cell suppressant activity
US5817308A (en) * 1994-02-14 1998-10-06 University Of Rochester Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance

Also Published As

Publication number Publication date
WO1995021926A1 (en) 1995-08-17
US6838281B2 (en) 2005-01-04
US20020048562A1 (en) 2002-04-25
DE69533979T2 (de) 2006-04-27
PT741788E (pt) 2005-05-31
CA2182977A1 (en) 1995-08-17
US5817308A (en) 1998-10-06
JP2008001709A (ja) 2008-01-10
ES2233940T3 (es) 2005-06-16
DE69533979D1 (de) 2005-03-10
ATE288494T1 (de) 2005-02-15
EP0741788A1 (de) 1996-11-13
JP4214173B2 (ja) 2009-01-28
DE69533979T8 (de) 2006-11-09
EP0741788B1 (de) 2005-02-02
JPH09509316A (ja) 1997-09-22

Similar Documents

Publication Publication Date Title
DK0741788T3 (da) Induktion af tolerans med tolerogene fusionsproteiner
DK0700445T3 (da) Stressproteiner og anvendelser deraf
Sell Studies on rabbit lymphocytes in vitro: VI. The induction of blast transformation with sheep antisera to rabbit IgA and IgM
ATE130765T1 (de) Gentechnologisch veränderte immunglobuline.
ATE353362T1 (de) Neuartige ctla4/cd28 liganden und deren anwendungen
Melcher et al. Cell Surface Immunoglobulin: XVI. Polypeptide Chain Structure of Mouse IgM and IgD-like Molecule
EP0571613A4 (en) Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
DE3484664D1 (de) Rekombinante immunoglobulin-praeparate, verfahren zu ihrer herstellung, dna-sequenzen, expressionsvektoren und rekombinante wirkzellen hierfuer.
SE9201331D0 (sv) Protein l och hybridproteiner daerav
DK0699755T3 (da) Fremgangsmåde til opnåelse af modificerede immunglobuliner med reduceret immunogenicitet af variable domæner i et murint antistof, præparater der indeholder disse
Tissot et al. IgM are associated to Spα (CD5 antigen‐like)
ATE368052T1 (de) Cd8 tuberkulose impfstoffe
DK0561907T3 (da) Proteiner med ændrede epitoper og fremgangsmåder til fremstilling deraf
Lamy et al. Arthropod hemocyanin structure: isolation of eight subunits in the scorpion
DE69034100D1 (de) Verktorvermittelte genominsertion und expression von dna in bcg
JPS6456697A (en) Viii factor bonded domain of von willebrand's factor
ATE298798T1 (de) Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin
DE69328726D1 (de) Verwendung synthetischer peptide zur induktion der toleranz gegen t- und b-zell epitope von autoantigenen
ZA9210006B (en) Anti-human IgE monoclonal antibodies.
Pedersen et al. Antigenic Analysis of Treponema pallidum: Cross‐reactions between Individual Antigens of T. pallidum and T. Reiter
SG95574A1 (en) Immunoreactive antigens of hepatitia e virus
DK0625157T3 (da) Blodplade-GPIIIaP1A1- og -P1A2-epitoper og fremstilling og anvendelse deraf
Itoh et al. Synthesis and secretion of alpha 1-microglobulin by human lymphocytes.
Trieshmann Jr et al. The characterization of human anti-IgG autoantibodies by liquid isoelectric focussing
WO1999042478A3 (en) LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL32